Theriva Biologics Inc KOL Webinar Transcript



Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TOVX.A - Theriva Biologics Inc
Theriva Biologics Inc KOL Webinar
Nov 07, 2022 / 04:00PM GMT

=====================
Conference Call Participants
=====================
* James Francis Molloy
Alliance Global Partners, Research Division - MD of Equity Research and Biotechnology & Specialty Pharmaceuticals Equity Research Analyst
* Arsen Osipov
* Michael A. Morse
* Michael Cozart

=====================
Presentation
--------------------------------------------------------------------------------
Michael Cozart, [1]
--------------------------------------------------------------------------------
Good morning, everyone, and thank you for joining today's KOL webinar. My name is Michael Cozart, and I'm a Managing Partner at LifeSci Consulting, a leading life sciences strategy consulting and transaction advisory firm located in New York City.

This morning, we will be discussing Theriva's novel oncolytic virus program, and in particular, the program's potential to treat pancreatic
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot